background image

Press Releases

Nov 22, 2021

Day One Announces First Patient Dosed in Phase 2 Monotherapy Study in RAF-altered Solid Tumors

Read more...

Nov 18, 2021

Day One to Present at the Piper Sandler 33rd Annual Virtual Healthcare Conference

Read more...

Nov 08, 2021

Day One Reports Third Quarter 2021 Financial Results and Corporate Progress

Read more...

Nov 03, 2021

Day One Announces Presentation at 2021 Connective Tissue Oncology Society (CTOS) Virtual Annual Meeting

Read more...

Sep 13, 2021

Day One Appoints Jaa Roberson as Chief People Officer

Read more...

Aug 17, 2021

Day One Appoints Scott Garland to Board of Directors

Read more...

Aug 10, 2021

Day One Reports Second Quarter 2021 Financial Results and Corporate Progress

Read more...

Aug 04, 2021

Day One Biopharmaceuticals to Participate at the 2021 Wedbush PacGrow Healthcare Virtual Conference

Read more...

Jul 27, 2021

Day One Receives FDA Rare Pediatric Disease Designation for DAY101 for the Treatment of Pediatric Low-Grade Glioma

Read more...

Jun 21, 2021

Day One Receives Orphan Designation from the European Commission for DAY101 for the Treatment of Glioma

Read more...
Displaying 1 - 10 of 17